These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8599988)

  • 21. Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
    Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
    Leuk Res; 2003 Feb; 27(2):183-91. PubMed ID: 12526924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tamoxifen on cell lines displaying the multidrug-resistant phenotype.
    Berman E; Adams M; Duigou-Osterndorf R; Godfrey L; Clarkson B; Andreeff M
    Blood; 1991 Feb; 77(4):818-25. PubMed ID: 1993221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
    Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
    Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia.
    Ferrao P; Sincock P; Cole S; Ashman L
    Leuk Res; 2001 May; 25(5):395-405. PubMed ID: 11301107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
    Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia.
    Fujimaki S; Funato T; Harigae H; Fujiwara J; Kameoka J; Meguro K; Kaku M; Sasaki T
    Clin Chem; 2002 Jun; 48(6 Pt 1):811-7. PubMed ID: 12028995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia.
    Albertioni F; Gruber A; Areström I; Vitols S
    Med Oncol; 1995 Jun; 12(2):79-86. PubMed ID: 8535665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
    Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
    Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein.
    Nielsen D; Maare C; Skovsgaard T
    Biochem Pharmacol; 1994 Jun; 47(12):2125-35. PubMed ID: 7913318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidrug resistance phenotype in leukaemic cells from patients with acute myelocytic leukaemia can be detected with 99Tc(m)-MIBI.
    Gruber A; Areström I; Xu D; Liliemark J; Larsson SA; Jacobsson H
    Br J Cancer; 1998 Jun; 77(11):1732-6. PubMed ID: 9667640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
    Marie JP; Faussat-Suberville AM; Zhou D; Zittoun R
    Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-glycoprotein 170 expression and function as an adverse independent prognostic factor in childhood acute lymphoblastic leukemia.
    Casale F; D'Angelo V; Addeo R; Caraglia M; Crisci S; Rondelli R; Di Tullio MT; Indolfi P
    Oncol Rep; 2004 Dec; 12(6):1201-7. PubMed ID: 15547738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of multidrug resistance in patients with leukemia by using flow cytometry and RNA in situ hybridization].
    Li S; Wang C; Yao C
    Zhonghua Nei Ke Za Zhi; 1996 Sep; 35(9):591-4. PubMed ID: 9592351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia.
    Pallis M; Turzanski J; Harrison G; Wheatley K; Langabeer S; Burnett AK; Russell NH
    Br J Haematol; 1999 Feb; 104(2):307-12. PubMed ID: 10050713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
    Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ
    Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia.
    Gruber A; Vitols S; Norgren S; Areström I; Peterson C; Björkholm M; Reizenstein P; Luthman H
    Br J Cancer; 1992 Aug; 66(2):266-72. PubMed ID: 1380280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.
    Beksaç M; Akan H; Koç H; Ilhan O; Ertürk S; Güneyli A; Ikizünal Y; Sardaş OS
    Med Oncol Tumor Pharmacother; 1992; 9(2):101-5. PubMed ID: 1364132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.